5 Articles suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Wafik El-Deiry shared a few must-reads paper on X:
Authors: Keren Papier et al.
Authors: Dhruva Biswas et al.
Pitfalls and perils from FDA-approved germ-line cancer predisposition tests
Authors: Wafik S El-Deiry and Eli Y Adashi
Authors: Kaimin Hu et al.
Authors: Xiaorui Su et al.
Further Reading:
5 Articles in Immunotherapy suggested by Wafik El-Deiry
ORACLE Lung Cancer Test: Predicting Survival for Early-Stage Lung Cancer Patients
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023